- As indicated in the joint announcement of March 11, 2025, the completion of the Block Acquisition remains subject to the usual closing conditions
- Subject to the fulfilment of the closing conditions, Zydus will acquire 85.6% of the share capital of Amplitude.
- The closing of the Block Acquisition is now expected to be completed by Q3 2025
NE BUSINESS BUREAU
AHMEDABAD, INDIA / VALENCE, FRANCE, APL 26
Zydus Lifesciences has signed the share purchase agreement to acquire 75.4% of the share capital of Amplitude Surgical SA at a price of €6.25 per Amplitude share from PAI Partners, Olivier Jallabert and other managers of Amplitude, which together with the two share purchase agreements already signed on 11 March 2025 with two minority shareholders represent 85.6% of the share capital of Amplitude.
As indicated in the joint announcement of March 11, 2025, the completion of the Block Acquisition remains subject to the usual closing conditions, including authorization from the French Minister of Economy as part of the control of foreign investments in France, the re-investment by Amplitude CEO Olivier Jallabert into the company, as well as the absence of qualified material adverse events.
Subject to the fulfilment of the closing conditions, Zydus will acquire 85.6% of the share capital of Amplitude.
The closing of the Block Acquisition is now expected to be completed by Q3 2025. After such completion, Zydus’ mandatory simplified tender offer would be filed with the Autorité des Marchés Financiers and would be followed by a squeeze out if the conditions are met. The opening of the subsequent tender offer would then remain subject to the AMF’s clearance decision.
In this respect and as announced on April 17, 2025, commitments to tender 4.7% of Amplitude’s share capital have been executed with other minority shareholders of Amplitude. As a consequence, and subject to the condition precedents hereabove, Zydus will be in a position to acquire more than 90 % of the capital and voting rights of Amplitude at the end of the tender offer, and therefore to implement a squeeze-out procedure.
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics. Amplitude Surgical develops and markets high end products for orthopaedic surgery, covering the main pathologies affecting the hip and knee.
